Accounts Receivable, after Allowance for Credit Loss, Current of Akso Health Group from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Akso Health Group quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Mar 2018 to 30 Sep 2025.
Akso Health Group Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2025 was $3,169,671, a 676% increase year-over-year.
Source SEC data: View on sec.gov

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Akso Health Group Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$3,169,671	+$2,761,437	+676%	30 Sep 2025	6-K	10 Feb 2026	2026	Q2
Q1 2025	$954,200			31 Mar 2025	6-K	10 Feb 2026	2026	Q2
Q3 2024	$408,234	-$5,419,683	-93%	30 Sep 2024	6-K	28 Mar 2025	2025	Q2
Q3 2023	$5,827,917			30 Sep 2023	6-K	03 Jan 2024	2024	Q2
Q1 2023	$7,696,983			31 Mar 2023	20-F	30 Jul 2024	2024	FY
Q1 2019	$140,639	+$140,639		31 Mar 2019	20-F	31 Jul 2019	2019	FY
Q1 2018	$0			31 Mar 2018	20-F	31 Jul 2019	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.